Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-12-11Clinical Trial Update: Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter [Phase 4]
A completed Phase 4 clinical study evaluating retrieval of the Günther Tulip vena cava filter, conducted in patients with pulmonary embolism…
-
CLINICAL_TRIALS trial_result · 2007-11-21Clinical Trial Update: Risk Stratification for Patients Presenting With Acute Pulmonary Embolism (PE)
This clinical trial update notes that a study on risk stratification for patients presenting with acute pulmonary embolism has been terminat…
-
CLINICAL_TRIALS trial_result · 2007-11-05Clinical Trial Update: Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism
A completed clinical trial sponsored by Atlantic Health System evaluated whether obstructive sleep apnea is a risk factor for pulmonary embo…
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery [Phase 2]
Pfizer completed a Phase 2 trial evaluating PD 0348292 for preventing venous thromboembolism (deep vein thrombosis and pulmonary embolism) a…
-
FDA approval · 2007-07-11FDA Approved: WARFARIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Warfarin Sodium from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-06-11Clinical Trial Update: Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing [NA]
This clinical trial update discusses modeling genotype and other factors to improve the safety of warfarin (Coumadin) prescribing. It covers…
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial [Phase 4]
A Phase 4 trial evaluating dalteparin for patients with knee-to-ankle fractures has completed, studying the risks of deep vein thrombosis an…
-
FDA approval · 2007-01-12FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for ENOXAPARIN SODIUM submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2006-10-17Clinical Trial Update: Deferment of Imaging for Pulmonary Embolism [Phase 4]
Phase 4 trial update indicating the study examining deferment of imaging for pulmonary embolism has been completed.
-
FDA approval · 2006-10-04FDA Approved: HEPARIN SODIUM — Supplemental Application (Civica, Inc.)
The FDA approved Civica, Inc.'s supplemental application for Heparin Sodium. This action updates the product labeling as part of the NDA 017…
-
CLINICAL_TRIALS trial_result · 2006-10-04Clinical Trial Update: Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes
This clinical trial update discusses long-term outcomes related to inferior vena cava (IVC) filters after retrieval failure, with the trial …
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE [Phase 4]
Phase 4 trial comparing 3 months versus 6 months of anticoagulation in patients with deep vein thrombosis and/or pulmonary embolism; the stu…
-
FDA approval · 2006-05-05FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for JANTOVEN (warfarin sodium) from Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2006-05-03Clinical Trial Update: Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) [Phase 3]
Phase 3 CANPEDS trial for suspected pulmonary embolism and deep vein thrombosis was terminated.